Product innovations > White / Technical Paper
Fill form to download now!
Please note that any information that you supply is protected by our Privacy Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
Future in ophthalmic delivery will go through preservative free multidose packaging
|
About two thirds of the ophthalmic packaging market is taken by multidose eyedroppers. They require preservatives in the drug to avoid bacterial contamination.
The most common preservative is benzalkonium chloride. It can have variable consequences for patients, from allergy to cornea damage when used in chronic treatments.
The role of preservatives in ophthalmic solutions is to avoid bacterial contamination inside the bottle during the treatment duration.
The objective of the new multidose ophthalmic packaging is to avoid preservatives into the solution while maintaining the sterility of the solution during treatment duration.
